b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29743444</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>10</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>10</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1880-3989</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>43</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The Journal of toxicological sciences</Title>\n                <ISOAbbreviation>J Toxicol Sci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Protective effects of rutin on lipopolysaccharide-induced heart injury in mice.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>329-337</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.2131/jts.43.329</ELocationID>\n            <Abstract>\n                <AbstractText>Rutin has a wide range of beneficial health properties in the amelioration of multi-organ injury owing to its various biological effects. The aim of this study was to investigate the effects of rutin on lipopolysaccharide (LPS)-induced heart injury and clarify its potential cardioprotective mechanism. The mouse model of heart injury was intraperitoneal infection with LPS, and rutin was orally administered for 8 consecutive days. One day after LPS injection, heart histopathology, cardiac marker enzymes and cardiac fibrosis related genes were determined to evaluate the cardioprotective effects of rutin. In addition, oxidative parameters and inflammatory cytokines were tested to explore its possible underlying mechanism. The presented results showed that rutin significantly improved morphological changes of myocardium and relieved cardiac marker enzymes [creatine kinase (CK) and lactate dehydrogenase (LDH)] level to protect heart in LPS-induced sepsis. And more, rutin observably mitigated fibrosis related genes [matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9)] expression in the heart to prevent against LPS-induced cardiac fibrosis. In addition, rutin markedly increased antioxidant enzymes [superoxide dismutase (SOD) and catalase (CAT)] activity, and improved oxidative production [malondialdehyde (MDA) and H<sub>2</sub>O<sub>2</sub>] level to balance the oxidation and anti-oxidation systems in the heart. Lastly, rutin dramatically ameliorated [tumor necrosis factor \xce\xb1 (TNF-\xce\xb1) and interleukin 6 (IL-6)] activity to restrain inflammatory responses in the heart. In conclusion, rutin possessed anti-oxidant and anti-inflammatory properties to improve LPS-induced heart injury, which suggested rutin could be used as a potential cardioprotective medicine in sepsis.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Xianchu</LastName>\n                    <ForeName>Liu</ForeName>\n                    <Initials>L</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lan</LastName>\n                    <ForeName>Zheng</ForeName>\n                    <Initials>Z</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ming</LastName>\n                    <ForeName>Liu</ForeName>\n                    <Initials>L</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yanzhi</LastName>\n                    <ForeName>Mo</ForeName>\n                    <Initials>M</Initials>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Japan</Country>\n            <MedlineTA>J Toxicol Sci</MedlineTA>\n            <NlmUniqueID>7805798</NlmUniqueID>\n            <ISSNLinking>0388-1350</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>4Y8F71G49Q</RegistryNumber>\n                <NameOfSubstance UI="D008315">Malondialdehyde</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>5G06TVY3R7</RegistryNumber>\n                <NameOfSubstance UI="D012431">Rutin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.1.1.27</RegistryNumber>\n                <NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.15.1.1</RegistryNumber>\n                <NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.3.2</RegistryNumber>\n                <NameOfSubstance UI="D003402">Creatine Kinase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.4.24.24</RegistryNumber>\n                <NameOfSubstance UI="D020778">Matrix Metalloproteinase 2</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.4.24.35</RegistryNumber>\n                <NameOfSubstance UI="D020780">Matrix Metalloproteinase 9</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000893" MajorTopicYN="Y">Anti-Inflammatory Agents</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000975" MajorTopicYN="Y">Antioxidants</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002316" MajorTopicYN="Y">Cardiotonic Agents</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003402" MajorTopicYN="N">Creatine Kinase</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006335" MajorTopicYN="N">Heart Injuries</DescriptorName>\n                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>\n                <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008315" MajorTopicYN="N">Malondialdehyde</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020778" MajorTopicYN="N">Matrix Metalloproteinase 2</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020780" MajorTopicYN="N">Matrix Metalloproteinase 9</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName>\n                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012431" MajorTopicYN="N">Rutin</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Anti-inflammatory</Keyword>\n            <Keyword MajorTopicYN="N">Anti-oxidant</Keyword>\n            <Keyword MajorTopicYN="N">Heart</Keyword>\n            <Keyword MajorTopicYN="N">Lipopolysaccharide</Keyword>\n            <Keyword MajorTopicYN="N">Rutin</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>5</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29743444</ArticleId>\n            <ArticleId IdType="doi">10.2131/jts.43.329</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'